These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35943265)

  • 1. Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.
    Brunaugh AD; Walz A; Warnken Z; Pearce C; Munoz Gutierrez J; Koleng JJ; Smyth HDC; Gonzalez-Juarrero M
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0018622. PubMed ID: 35943265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization.
    Brunaugh AD; Jan SU; Ferrati S; Smyth HDC
    Mol Pharm; 2017 Nov; 14(11):4019-4031. PubMed ID: 29047275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
    Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
    Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
    Xu J; Lu Y; Fu L; Zhu H; Wang B; Mdluli K; Upton AM; Jin H; Zheng M; Zhao W; Li P
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1119-25. PubMed ID: 22691726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
    Mashele SA; Steel HC; Matjokotja MT; Rasehlo SSM; Anderson R; Cholo MC
    J Glob Antimicrob Resist; 2022 Jun; 29():343-352. PubMed ID: 35339735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofazimine: A useful antibiotic for drug-resistant tuberculosis.
    Mirnejad R; Asadi A; Khoshnood S; Mirzaei H; Heidary M; Fattorini L; Ghodousi A; Darban-Sarokhalil D
    Biomed Pharmacother; 2018 Sep; 105():1353-1359. PubMed ID: 30021373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofazimine inhibits innate immunity against
    Li X; Luo X; Wang B; Fu L; Chen X; Lu Y
    mSphere; 2024 Aug; 9(8):e0025424. PubMed ID: 39046230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.
    Irwin SM; Gruppo V; Brooks E; Gilliland J; Scherman M; Reichlen MJ; Leistikow R; Kramnik I; Nuermberger EL; Voskuil MI; Lenaerts AJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4026-34. PubMed ID: 24798275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of
    Lanoix JP; Joseph C; Peltier F; Castelain S; Andréjak C
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.
    Gopal M; Padayatchi N; Metcalfe JZ; O'Donnell MR
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1001-7. PubMed ID: 23541151
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis in Different Administration Intervals in Mouse Tuberculosis Models.
    Zhu H; Fu L; Wang B; Chen X; Zhao J; Huang H; Lu Y
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China.
    Li G; Xu Z; Jiang Y; Liu H; Zhao LL; Li M; Xu D; Zhao X; Liu Z; Wang R; Wan K
    Int J Antimicrob Agents; 2019 Nov; 54(5):642-646. PubMed ID: 31200023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
    Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
    Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.
    Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
    Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
    J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice.
    Verma RK; Germishuizen WA; Motheo MP; Agrawal AK; Singh AK; Mohan M; Gupta P; Gupta UD; Cholo M; Anderson R; Fourie PB; Misra A
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1050-2. PubMed ID: 23183441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.